1. Home
  2. RXRX vs LGND Comparison

RXRX vs LGND Comparison

Compare RXRX & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • LGND
  • Stock Information
  • Founded
  • RXRX 2013
  • LGND 1987
  • Country
  • RXRX United States
  • LGND United States
  • Employees
  • RXRX N/A
  • LGND N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • RXRX Health Care
  • LGND Health Care
  • Exchange
  • RXRX Nasdaq
  • LGND Nasdaq
  • Market Cap
  • RXRX 2.0B
  • LGND 2.0B
  • IPO Year
  • RXRX 2021
  • LGND 1992
  • Fundamental
  • Price
  • RXRX $5.67
  • LGND $120.25
  • Analyst Decision
  • RXRX Buy
  • LGND Strong Buy
  • Analyst Count
  • RXRX 5
  • LGND 8
  • Target Price
  • RXRX $7.00
  • LGND $144.71
  • AVG Volume (30 Days)
  • RXRX 31.0M
  • LGND 139.7K
  • Earning Date
  • RXRX 08-07-2025
  • LGND 08-05-2025
  • Dividend Yield
  • RXRX N/A
  • LGND N/A
  • EPS Growth
  • RXRX N/A
  • LGND N/A
  • EPS
  • RXRX N/A
  • LGND N/A
  • Revenue
  • RXRX $59,790,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • RXRX $23.51
  • LGND $18.41
  • Revenue Next Year
  • RXRX $53.87
  • LGND $18.87
  • P/E Ratio
  • RXRX N/A
  • LGND N/A
  • Revenue Growth
  • RXRX 29.32
  • LGND 53.40
  • 52 Week Low
  • RXRX $3.79
  • LGND $81.74
  • 52 Week High
  • RXRX $12.36
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 60.23
  • LGND 67.64
  • Support Level
  • RXRX $4.80
  • LGND $111.72
  • Resistance Level
  • RXRX $5.44
  • LGND $115.53
  • Average True Range (ATR)
  • RXRX 0.40
  • LGND 3.19
  • MACD
  • RXRX 0.03
  • LGND 0.04
  • Stochastic Oscillator
  • RXRX 90.00
  • LGND 95.79

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: